B

Bio-Rad Laboratories
D

BIO/B

312.05
USD
0.65
(0.21%)
مغلق
حجم التداول
0
الربح لكل سهم
9
العائد الربحي
-
P/E
-5
حجم السوق
8,736,390,518
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ABBV
    ABBV
    1.200
    (0.60%)
    202.140 USD
    AMGN
    AMGN
    5.10
    (1.71%)
    303.15 USD
    BIIB
    BIIB
    3.560
    (2.60%)
    140.630 USD
    GILD
    GILD
    -0.140
    (-0.13%)
    109.920 USD
    JNJ
    JNJ
    2.680
    (1.68%)
    162.370 USD
    LLY
    LLY
    0.67
    (0.08%)
    874.04 USD
    MRK
    MRK
    1.820
    (2.08%)
    89.500 USD
    PFE
    PFE
    0.405
    (1.56%)
    26.305 USD
    REGN
    REGN
    4.37
    (0.63%)
    700.66 USD
    المزيد
الأخبار
المقالات

العنوان: Bio/Rad Laboratories

القطاع: Healthcare
الصناعة: Medical Devices
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.